Search results for "immunoglobulin"

More Than Eye Irritation: Long-Term Fine Dust Exposure May Trigger Systemic Immune Shifts

More Than Eye Irritation: Long-Term Fine Dust Exposure May Trigger Systemic Immune Shifts

As one of the organs most directly exposed to the external environment, the human eye is exceptionally vulnerable to deteriorating air quality.
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs

SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs

SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its lineup following the August...
Blurry Vision and Sudden Limb Weakness Could Signal Multiple Sclerosis, Not Just Stroke

Blurry Vision and Sudden Limb Weakness Could Signal Multiple Sclerosis, Not Just Stroke

When vision suddenly turns cloudy in one eye and an arm or leg feels unexpectedly weak, many patients immediately fear...
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial

VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial

Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by...
Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo,...
Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder

Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder

Patients suffering from light-chain amyloidosis, a rare and debilitating blood disorder that causes abnormal proteins...
Eli Lilly to Acquire GC Biopharma’s Curevo Vaccine in Blockbuster $1.5 Billion Deal

Eli Lilly to Acquire GC Biopharma’s Curevo Vaccine in Blockbuster $1.5 Billion Deal

GC Biopharma’s U.S. affiliate, Curevo Vaccine, is set to be acquired by global pharmaceutical giant Eli Lilly in a deal...
The End of the MRI? New Blood Test Tracks Brain Disease in Minutes

The End of the MRI? New Blood Test Tracks Brain Disease in Minutes

A new path has opened for patients with neurological conditions to monitor their disease progression through a simple...
90 Minutes in the Forest: How Nature Reshapes Your Immune Response

90 Minutes in the Forest: How Nature Reshapes Your Immune Response

New research is bringing fresh attention to the "forest effect," revealing that the body's immune response can vary...